Loading clinical trials...
Loading clinical trials...
The trial will evaluate the safety of one dose regimen of H-1337 \[1% twice daily (b.i.d.)\] in both eyes in healthy volunteers.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
D. Western Therapeutics Institute, Inc.
NCT07390890 · Primary Open Angle Glaucoma, Ocular Hypertension
NCT05902871 · Primary Open Angle Glaucoma, Ocular Hypertension, and more
NCT07218796 · Cataract, Glaucoma, and more
NCT07119580 · Glaucoma, Ocular Hypertension, and more
NCT07076303 · Primary Open Angle Glaucoma, Glaucoma, and more
Eye Research Foundation Inc.
Newport Beach, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions